NASDAQ:MBIO
Mustang Bio Inc Stock News
$0.335
+0.0231 (+7.40%)
At Close: May 20, 2024
Global CAR T Cell Therapy Market to 2026 - by Regions, Targeted Antigens, Clinical Trials/Study & Companies - ResearchAndMarkets.com
12:00am, Wednesday, 24'th Jun 2020
The
Mustang Bio (NASDAQ:MBIO) Shares Gap Up to $3.40
06:16am, Friday, 19'th Jun 2020
Mustang Bio Inc (NASDAQ:MBIO) gapped up before the market opened on Wednesday . The stock had previously closed at $3.27, but opened at $3.40. Mustang Bio shares last traded at $3.45, with a volume of
Do Options Traders Know Something About Mustang Bio (MBIO) Stock We Don't?
12:39pm, Wednesday, 17'th Jun 2020
Investors need to pay close attention to Mustang Bio (MBIO) stock based on the movements in the options market lately.
-$0.28 EPS Expected for Mustang Bio Inc (NASDAQ:MBIO) This Quarter
07:30am, Monday, 15'th Jun 2020
Wall Street analysts expect Mustang Bio Inc (NASDAQ:MBIO) to announce earnings per share of ($0.28) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Mustang Bio�
Mustang Bio Announces Pricing of Public Offering of Common Stock
01:00pm, Thursday, 11'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
Mustang Bio (MBIO) Jumps: Stock Rises 8.2%
12:51pm, Thursday, 11'th Jun 2020
Mustang Bio (MBIO) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Mustang Bio Announces Proposed Public Offering of Common Stock
08:01pm, Wednesday, 10'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
Les valeurs à suivre aujourd'hui à la Bourse de Paris Mercredi 10 juin 2020
07:01am, Wednesday, 10'th Jun 2020Celyad devient Celyad Oncology
12:00am, Wednesday, 10'th Jun 2020
Regulatory News: Celyad SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), une société biotechnologique de stade clinique fo
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
02:17pm, Thursday, 04'th Jun 2020
CAMBRIDGE, Mass., June 4, 2020 /PRNewswire via COMTEX/ --
CAMBRIDGE, Mass., June 4, 2020 /PRNewswire/ -- Artax Biopharma, Inc., a biotechnology company...
Mustang Bio to Host Virtual Annual Meeting of Stockholders
12:30pm, Thursday, 04'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
Startup targets glioblastoma tumors with CAR-T therapy
03:00pm, Wednesday, 27'th May 2020
Scientists at McMaster University and the University of Toronto have developed a CAR-T therapy targeting CD133 for aggressive brain cancer glioblastoma. The CAR-Ts are showing promise in mouse models,
Trade Alert: The President Of Mustang Bio, Inc. (NASDAQ:MBIO), Manuel Litchman, Has Just Spent US$533k Buying 545% More Shares
10:39am, Monday, 25'th May 2020
Mustang Bio, Inc. (NASDAQ:MBIO) shareholders (or potential shareholders) will be happy to see that the President...
Is Mustang (MBIO) Stock a Solid Choice Right Now?
12:32pm, Thursday, 21'st May 2020
Mustang (MBIO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
City of Hope Physicians/Scientists Lead Multiple, Innovative COVID-19 Research Projects
12:00am, Thursday, 21'st May 2020
City of Hope’s physician-scientists and basic scientists are using their expertise to attack the deadly coronavirus on multiple research fronts.
